Global Ligases Enzyme Market 2024 Competitive Landscape, Industry Analysis, Segmentation And Forecast To 2033 | Major Players Are BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson And Company (BD).

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Ligases Enzyme Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The ligases enzyme market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to initial discovery and development of ligase enzymes, growth of the biotechnology industry, increased understanding of dna repair mechanisms, expansion of genetic engineering applications, rise in demand for molecular diagnostics.

The ligases enzyme market size is expected to see rapid growth in the next few years. It will grow to $4.92 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of personalized medicine applications, growing focus on synthetic biology, adoption of ligase enzymes in drug development, increased demand for molecular diagnostics, integration of ligases in next-generation sequencing. Major trends in the forecast period include development of engineered ligases for specific applications, integration of ligase enzymes in crispr-based technologies, customization of ligase-based assays for research and diagnostics, rise of ligase-based isothermal amplification methods, adoption of ligase chain reaction (lcr) in diagnostic assays.

Get Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12226&type=smp

Market Segmentation:
The ligases enzyme market covered in this report is segmented -
1) By Type: E. coli DNA ligase, T4 DNA Ligase, Mammalian Ligases, Thermostable Ligases
2) By Source: Microorganisms, Animal, Plant
3) By Application: Ligase Chain Reaction (LCR), Ligase Detection Reaction (LDR), Next-Generation Sequencing (NGS), Repeat Expansion Detection (RED), Rolling Circle Amplification (RCA), Proximity Ligation Assay (PLA), Molecular Cloning, Ligation Mediated PCR, Mutation Detection
4) By End-User: Research Laboratories And Institutions, Pharmaceutical And Biopharmaceutical Companies, Diagnostic Laboratories

Major Driver - Ligase Enzymes Market Surge Addressing The Rising Tide Of Cancer And Genetic Disorders
The increasing prevalence of cancer and genetic disorders is expected to propel the growth of the ligase's enzyme market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, and genetic disorders refer to a wide range of medical conditions caused by abnormalities or mutations in an individual's genetic material, particularly in their DNA. Ligases enzymes are essential for DNA replication, repair, and recombination. In cancer, ligases can be used to repair damaged DNA, leading to the uncontrolled growth of cells. Ligases can also be used to target and kill cells with genetic disorders. For instance, in June 2023, according to the reports shared by the Centers for Disease Control and Prevention, a US-based government agency, in the United States, 1,603,844 new instances of cancer were reported in 2020, and 602,347 cancer-related deaths were recorded. Furthermore, 403 new cancer cases and 144 cancer-related deaths were reported for every 100,000 people. Furthermore, in February 2023, according to Gene People UK, a UK-based registered charity group, around 1 in 25 children are affected by a genetic condition in the UK, leading to more than 2.4 million children and adults in the UK living with a genetic disorder, and 30,000 babies and children are newly diagnosed each year. Therefore, the increasing prevalence of cancer and genetic disorders is driving the growth of the ligase's enzyme market.

Competitive Landscape:
Major companies operating in the ligases enzyme market report are BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Novo Holdings AS, GenScript, VWR International, R And D Systems Inc., Promega Corporation, Oxford Nanopore Technologies Limited, Takara Bio Inc., New England Biolabs Inc., BioVision Inc., Enzo Life Sciences, Zymo Research, LGC Biosearch Technologies, Genetix Biotech Asia Pvt. Ltd., BLIRT S.A., Jena Bioscience, Bioline, Creative Enzymes, ArcticZymes Technologies ASA

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ligases-enzyme-global-market-report

Top Trend - Product Innovations In The Ligase Enzymes Market
Product innovation is a key trend gaining popularity in the ligase's enzyme market. Major companies operating in the ligase's enzyme market are developing innovative ligases enzymes to sustain their position in the market. For instance, in December 2021, ArcticZymes Technologies ASA, a Norway-based biotechnology company, launched ArcticZymes R2D Ligase, an innovative patent-pending ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint. The enzyme is projected to be widely applicable in molecular diagnostics, next-generation sequencing, and gene and RNA synthesis applications for possible therapeutic applications. Additionally, it has a unique substrate specificity that allows it to ligate DNA to both the 5'- and the 3'-ends of RNA in the presence of a DNA template, positioning the lightable ends of DNA and RNA. It is highly active and efficient, making it ideal for various applications.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ligases Enzyme Market Characteristics
3. Ligases Enzyme Market Trends And Strategies
4. Ligases Enzyme Market - Macro Economic Scenario
5. Ligases Enzyme Market Size And Growth
…..
27. Ligases Enzyme Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

This release was published on openPR.